Oric Pharma director Richard A. Heyman disposes of 13,100 common shares worth $157,462.00

• Oric Pharmaceuticals director Richard A. Heyman sold 13,100 shares on July 24 at USD 12.02.
• He exercised options to acquire 3,500 shares at USD 1.6 on the same day.
• Directly held common stock ended at 38,300 shares.
• RAHD Capital held 206,672 shares indirectly following the sale.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oric Pharmaceuticals Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001584759-26-000015), on July 28, 2026, and is solely responsible for the information contained therein.